
Sign up to save your podcasts
Or


Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here.
By Dr. Neil Love4.4
6363 ratings
Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here.

136 Listeners

316 Listeners

497 Listeners

31 Listeners

73 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

120 Listeners

44 Listeners

58 Listeners

3,349 Listeners

1,146 Listeners

45 Listeners

369 Listeners

57 Listeners

0 Listeners